Recent News

United States VPM1002 (Tuberculosis BCG Based Vaccine) for Prevent Covid-19 Market By Application Report 2031

Introduction to VPM1081 Tuberculosis BCG Based Vaccine United States VPM1081, a tuberculosis vaccine based on the BCG strain, has garnered attention as a potential preventive measure against COVID-19. Originally developed to combat tuberculosis, VPM1081 has shown promise in enhancing the immune response against various respiratory infections, including coronaviruses. This vaccine […]